Fig. 2

Kaplan–Meier estimates of (a) progression-free and (b) overall survival and cumulative incidence estimates of (c) locoregional failure and (d) distant metastasis by assigned treatment. HR, hazard ratio; CCRT, Concurrent Chemoradiotherapy
Kaplan–Meier estimates of (a) progression-free and (b) overall survival and cumulative incidence estimates of (c) locoregional failure and (d) distant metastasis by assigned treatment. HR, hazard ratio; CCRT, Concurrent Chemoradiotherapy